These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37399948)

  • 21. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial.
    Niess H; von Einem JC; Thomas MN; Michl M; Angele MK; Huss R; Günther C; Nelson PJ; Bruns CJ; Heinemann V
    BMC Cancer; 2015 Apr; 15():237. PubMed ID: 25879229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.
    Cova E; Pandolfi L; Colombo M; Frangipane V; Inghilleri S; Morosini M; Mrakic-Sposta S; Moretti S; Monti M; Pignochino Y; Benvenuti S; Prosperi D; Stella G; Morbini P; Meloni F
    Int J Nanomedicine; 2019; 14():773-785. PubMed ID: 30774332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery.
    Petrella F; Rimoldi I; Rizzo S; Spaggiari L
    Medicines (Basel); 2017 Nov; 4(4):. PubMed ID: 29168760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.
    Zhang J; Khanna S; Jiang Q; Alewine C; Miettinen M; Pastan I; Hassan R
    Clin Cancer Res; 2017 Mar; 23(6):1564-1574. PubMed ID: 27635089
    [No Abstract]   [Full Text] [Related]  

  • 27. Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC).
    Cordani N; Lisini D; Coccè V; Paglia G; Meanti R; Cerrito MG; Tettamanti P; Bonaffini L; Paino F; Alessandri G; Marcianti A; Giannì A; Villa C; Mauri M; Mologni L; Torsello A; Pessina A; Cazzaniga ME
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
    Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
    Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
    Clavreul A; Pourbaghi-Masouleh M; Roger E; Lautram N; Montero-Menei CN; Menei P
    J Exp Clin Cancer Res; 2017 Sep; 36(1):135. PubMed ID: 28962658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant Pleural Mesothelioma: State of the art and advanced cell therapy.
    Facchetti G; Petrella F; Spaggiari L; Rimoldi I
    Eur J Med Chem; 2017 Dec; 142():266-270. PubMed ID: 28800871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
    Chahinian AP; Mandeli JP; Gluck H; Naim H; Teirstein AS; Holland JF
    J Surg Oncol; 1998 Feb; 67(2):104-11. PubMed ID: 9486781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
    Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
    Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.
    Liu R; Colby AH; Gilmore D; Schulz M; Zeng J; Padera RF; Shirihai O; Grinstaff MW; Colson YL
    Biomaterials; 2016 Sep; 102():175-86. PubMed ID: 27343465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stromal cells uptake and release paclitaxel without reducing its anticancer activity.
    Mariotti M; Colognato R; Rimoldi M; Rizzetto M; Sisto F; Cocce V; Bonomi A; Parati E; Alessandri G; Bagnati R; Pessina A
    Anticancer Agents Med Chem; 2015; 15(3):400-5. PubMed ID: 24942547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
    Brennen WN; Kisteman LN; Isaacs JT
    Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
    Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
    PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.
    Ohara Y; Enomoto A; Tsuyuki Y; Sato K; Iida T; Kobayashi H; Mizutani Y; Miyai Y; Hara A; Mii S; Suzuki J; Yamashita K; Ito F; Motooka Y; Misawa N; Fukui T; Kawaguchi K; Yokoi K; Toyokuni S
    Oncol Rep; 2020 Sep; 44(3):838-848. PubMed ID: 32705221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.
    Tamanna MT; Egbune C
    Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    Scioli MG; Artuso S; D'Angelo C; Porru M; D'Amico F; Bielli A; Gentile P; Cervelli V; Leonetti C; Orlandi A
    PLoS One; 2018; 13(9):e0203426. PubMed ID: 30192811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.